WilliamFranklinPendergraftMDPhD

Glomerular Disease

CEO, Integrative Medical Clinic of North Carolina

Dr. Pendergraft is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Integrative Medical Clinic of North Carolina
5915 Farrington Road, Suite 106
Chapel Hill, NC 27517
Phone+1 984-999-0902

Fax+1 984-439-2122

Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2010 - 2013
University of California (San Francisco)Residency, Internal Medicine, 2008 - 2010
University of North Carolina at Chapel Hill School of MedicineClass of 2008

PubMed

107 citations
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.
Y Atisha-Fregoso, Susan Malkiel, Kristina M. Harris, Margie Byron, Linna Ding
Arthritis & Rheumatology. 2021-01-01
7 citations
Publisher Correction: The immune cell landscape in kidneys of patients with lupus nephritis.
Arnon Arazi, Deepak A. Rao, Celine C. Berthier, Anne Davidson, Yanyan Liu
Nature Immunology. 2019-08-13
460 citations
The immune cell landscape in kidneys of patients with lupus nephritis
Arnon Arazi, Deepak A. Rao, Celine C. Berthier, Anne Davidson, Yanyan Liu
Nature Immunology. 2019-06-17

Journal Articles

A Randomized, Controlled Double-Blind Study Comparing the Efficacy and Safety of Dose-Ranging Voclosporin with Placebo in Achieving Remission in Patients with Active L...
Brad H Rovin, William F Pendergraft, Kidney International